COLGATE PALMOLIVE CO(CL)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #229 of 2,879 stocksTOP 10%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
CL Stock Analysis & AI Quality Score
AI stock analysis and institutional research for COLGATE PALMOLIVE CO (CL), a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores CL at 72.4/100 on a 32-signal composite quality model, placing it at rank #229 of 2,879 stocks — the top 10% of the AI-ranked universe. CL scores in the top quartile across balance sheet strength (95.1), revenue scale (92.9), institutional flow (87.1). Based on the latest XBRL financial filings (Q1 2026), COLGATE PALMOLIVE CO reports quarterly revenue of $5.3B, net income of $646.0M, an operating margin of 18.1%. Top institutional holders of CL by reported 13-F value include BlackRock,, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. CL trades on the NYSE exchange and files with the SEC under CIK 21665. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for COLGATE PALMOLIVE CO directly from SEC EDGAR. COLGATE PALMOLIVE CO's 13F Pro composite quality score has ranged between 8 and 78 since 2021, currently 72.4 — a stable long-term trajectory across 56 quarterly and live scoring snapshots.
What's Driving CL's Business? Latest 10-Q Breakdown
AI-extracted from COLGATE PALMOLIVE CO's 10-Q filed 2026-05-01 — Q1 2026 (quarter ended March 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Net sales rose 8.4% YoY to $5.3B, but operating profit fell 10% to $964M due to $176M in Strategic Growth and Productivity Program charges.
Biggest Revenue Drivers
Total revenue: $5,324M+8.4% YoY
Volume growth of 1.3%, net selling price increases of 1.8%, and positive foreign exchange of 5.9%.
Volume growth of 0.2%, net selling price increases of 3.8%, and positive foreign exchange of 2.7%; Prime100 acquisition contributed 1.9%.
Largest Expense Items
Significantly higher raw and packaging material costs offset by cost savings from funding-the-growth initiatives.
Higher overhead expenses and increased advertising investment; included $6M from Strategic Growth and Productivity Program.
Margins: Gross profit margin declined 20 bps to 60.6% due to significantly higher raw and packaging material costs (350 bps), partially offset by funding-the-growth savings (230 bps). Operating profit margin fell 380 bps to 18.1% GAAP, but was 21.3% non-GAAP (90 bps decline), primarily from gross margin compression and higher SG&A.
Watch Items from the Filing
- Strategic Growth and Productivity Program expanded: cumulative charges now estimated at $350–$550M (increased from $200–$300M), with annualized savings of $200–$300M. Q1 2026 charges were $176M pre-tax.
- Raw and packaging material costs remained significantly elevated, up 350 bps gross margin pressure in Q1 2026, including tariff impacts; partially offset by pricing actions (80 bps) and cost-reduction initiatives (230 bps).
- Talcum powder litigation: 484 cases pending as of March 31, 2026 (vs. 453 at year-end 2025); 74 new cases filed and 43 resolved in Q1. Aggregate reasonably possible losses estimated at $0–$225M above accrued amounts.
- Brazilian tax matters: approximately $103M in assessments (interest and penalties) under dispute since October 2001; one recent adverse ruling in December 2025 for $19M for years 1999–2001; company plans further appeals.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
Revenue
Q1 2026
$5.3B
Net Income
Q1 2026
$646.0M
Free Cash Flow
Q1 2026
$609.0M
Operating Margin
Q1 2026
18.1%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+15.4% YoYNet Income
+33.4% YoYOperating Income
+28.1% YoYEPS (Diluted)
+37.6% YoYTotal Assets
+6.7% YoYTotal Debt
+10.2% YoYOp. Cash Flow
+23.5% YoY| Metric | FY 2024 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2016 |
|---|---|---|---|---|---|---|
| Revenue | $20.10B +15.4% | $17.42B +5.8% | $16.47B +5.0% | $15.69B +1.0% | $15.54B +2.3% | $15.20B |
| Net Income | $2.89B +33.4% | $2.17B -19.6% | $2.69B +13.9% | $2.37B -1.4% | $2.40B -1.7% | $2.44B |
| Operating Income | $4.27B +28.1% | $3.33B -14.2% | $3.88B +9.3% | $3.55B -3.8% | $3.69B -6.6% | $3.96B |
| EPS (Diluted) | $3.51 +37.6% | $2.55 -18.8% | $3.14 +14.2% | $2.75 +0.0% | $2.75 +1.1% | $2.72 |
| Total Assets | $16.05B +6.7% | $15.04B -5.5% | $15.92B +5.9% | $15.03B +23.6% | $12.16B +0.3% | $12.12B |
| Total Debt | $7.94B +10.2% | $7.21B -1.9% | $7.34B -3.2% | $7.59B +19.4% | $6.35B -2.5% | $6.52B |
| Operating Cash Flow | $4.11B +23.5% | $3.33B -10.6% | $3.72B +18.7% | $3.13B +2.5% | $3.06B -2.7% | $3.14B |
AI Insight: CL Financial Trends
Q4 2025 saw operating income collapse 91% to $92M and net income swing to -$37M loss, though Q1 2026 showed partial recovery in topline and profitability.
• Revenue grew 5.4% from Q2 2024 ($5,059M) to Q1 2026 ($5,324M), driven by recent acceleration: Q4 2025 +5.8% and Q1 2026 +1.8% QoQ.
• Operating income collapsed in Q4 2025 to $92M (8.5% margin) from $1,063M average prior quarters, rebounding modestly to $964M in Q1 2026.
• Operating cash flow remained resilient, averaging $1,067M across eight quarters; Q1 2026 generated $747M despite profitability headwinds.
⚠ Total debt surged to $8,954M in Q4 2025 (highest in dataset), then declined to $7,937M in Q1 2026—leverage spike warrants explanation.
⚠ Q4 2025 net loss of -$37M and Q1 2026 recovery to $646M suggest one-time charge or operational disruption; underlying earnings quality unclear.
AI Insight: CL Ratio Trends
Colgate suffered a severe Q4 2025 collapse—operating margin cratered to 1.8% and ROIC plunged to 4.1%—though Q1 2026 shows partial recovery but remains well below pre-collapse levels.
• Operating margin contracted from 20.6% in Q3 2025 to 1.8% in Q4 2025, then recovered to 18.1% in Q1 2026, still 2.5pp below Q3 2025.
• ROIC fell from 51.8% in Q3 2025 to 4.1% in Q4 2025; Q1 2026 recovery to 47.7% confirms Q4 was exceptional disruption, not structural collapse.
• TTM ROIC now 39.5% vs. 52.1% in Q4 2024—a 12.6pp decline dragged down by Q4 2025 anomaly weighted in trailing twelve-month calculation.
⚠ Q4 2025 net profit margin turned negative (-0.7%), suggesting significant one-time charges or operational disruption requiring detailed disclosure.
⚠ Debt/equity ratio unavailable for recent quarters; D/E spiked to 37.46 in Q4 2024 before normalizing—monitor leverage post-Q4 disruption.
Get alerted when CL's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for COLGATE PALMOLIVE CO including:
Top Institutional Holders of CL
BlackRock, Inc.
$6.2B72,643,002 shVANGUARD CAPITAL MANAGEMENT LLC
$4.5B52,219,824 shSTATE STREET CORP
$4.1B47,719,482 shVANGUARD PORTFOLIO MANAGEMENT LLC
$2.0B23,822,746 shGEODE CAPITAL MANAGEMENT, LLC
$2.0B22,900,290 shMORGAN STANLEY
$1.8B20,881,354 shBank of New York Mellon Corp
$1.1B12,521,545 shDEUTSCHE BANK AG\
$1.0B11,928,161 shGOLDMAN SACHS GROUP INC
$807.6M9,475,834 shFMR LLC
$767.8M9,008,985 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $6.2B | 72,643,002 |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.5B | 52,219,824 |
| STATE STREET CORP | $4.1B | 47,719,482 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.0B | 23,822,746 |
| GEODE CAPITAL MANAGEMENT, LLC | $2.0B | 22,900,290 |
| MORGAN STANLEY | $1.8B | 20,881,354 |
| Bank of New York Mellon Corp | $1.1B | 12,521,545 |
| DEUTSCHE BANK AG\ | $1.0B | 11,928,161 |
| GOLDMAN SACHS GROUP INC | $807.6M | 9,475,834 |
| FMR LLC | $767.8M | 9,008,985 |
More Consumer Staples Companies
View all Consumer Staples →Put CL on your watchlist
Track score changes the day COLGATE PALMOLIVE CO files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CL a good stock to buy?
13F Pro's AI-powered analysis of COLGATE PALMOLIVE CO (CL) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Consumer Staples sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CL are available on the CL stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own CL?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CL. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of COLGATE PALMOLIVE CO's investment landscape.